ELLOVA®, A CLINICALLY PROVEN SOLUTION
The beneficial effect of EllOva® on infertility in PCOS women has been widely proven in literature.
Restoration of the ovulatory function
- Observational study
- n = 3.602 PCOS women
- Treatment protocol: Myo-inositol 4 g + Folic acid 400 μg
- Duration: 2-3 months
70% of infertile PCOS women had retrieved a normal ovulatory function within 2 to 3 months of supplementation.
Improvement of IVF outcomes
- Double-blind, randomized study
- n = 50 overweight PCOS women undergoing IVF
- Duration: 12 weeks
- Treatment protocol:
Treated group (n = 25): Myo-inositol 2 g + Folic acid 400 μg
Control group (n = 25): Folic acid 400 μg
By increasing the number of top-quality oocytes in PCOS women, Ellova® induced a clinical pregnancy in 40% of treated women vs 16% in the placebo group.